Irbesartan and Oseltamivir treatment of COVID-19 infection
Latest Information Update: 02 Jun 2023
At a glance
- Drugs Irbesartan (Primary) ; Oseltamivir (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Acronyms Covid-19 protection
- 02 Jun 2023 Status changed from recruiting to completed.
- 13 Oct 2020 New trial record